The plasma concentration of different lipoproteins were measured in 102 control children, in 42 children with a parent suffering from coronary heart disease (CHD), and in 50 children with a parent with cerebrovascular disease (CVD). Significant differences between controls and children in the other two groups were found for apolipoprotein A I, apolipoprotein B, and high density lipoproteincholesterol. Children of parents with CHD differed from controls in total cholesterol and apolipoprotein A II concentrations. A highly significant difference furthermore was found in lipoprotein (a) concentrations from children of parents with CHD in comparison with controls, but not between children of parents with CVD and controls. The difference in lipoprotein (a) concentrations (children of parents with CHD compared with controls) were only noticed in children above the age of 10 years. This could be explained by the observed rise of lipoprotein (a) between age 2 and 13 years, which was much more pronounced in the group with parents who had CHD. Plasma glycosaminoglycan concentrations were also measured in the three groups. They were significantly higher in children of parents with CHD and CVD compared with controls; they also varied with age.
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The pathophysiological events leading to atherosclerosis are known to originate already in early childhood.' In numerous reports multivariate analysis of prospective morbidity and mortality studies strongly suggest a family history for coronary heart disease (CHD) and cerebrovascular disease (CVD). In fact it appears that genetic and familial factors contribute most to the risk of atherosclerosis.2 As the causes for atherosclerosis are multifactorial, there is no single parameter that would allow prediction of the individual risk with sufficient certainty. Evidence is accumulating, however, that raised plasma lipoprotein (a) concentrations contribute to a great extent to atherogenesis especially if low density lipoprotein-cholesterol is increased in addition.' In a previous study we investigated 1500 young soldiers and based on a questionnaire they were divided into two groups: positive and negative family history of myocardial infarction. It was found that parents of children with premature myocardial infarction had significantly higher plasma lipoprotein (a) concentrations compared with healthy controls. 7 In this study we extended our previous work by investigating the children of people suffering from CHD and CVD separately. The data are not based on a questionnaire but derive from blood analysis of the children of affected patients directly.
Previous in vitro experiments in our laboratory, aimed at shedding more light on the possible molecular mechanism of the atherogenicity of lipoprotein (a), demonstrated that this lipoprotein avidly complexes with glycosaminoglycan, and this in turn is recognised by the scavenger receptors on macrophages.8 Such a process may favour the complex formation of lipoprotein (a) with intracellular matrices of arteries, followed by triggering of the onset of early lesions. As it is known that glycosaminoglycan is present in a variable concentration in circulating blood even in healthy people, we measured glycosaminoglycan concentrations in the serum of children and correlated them with age and familial atherosclerosis risk.
Subjects and methods
Ninety six children with an established familial risk for atherosclerosis between 2 and 15 years of age were investigated and compared with 102 control children matched for age and sex. This control group consisted of children who were admitted to hospital for various reasons not connected with acute diseases or metabolic defects, for example, tonsillectomy.
The children at risk for atherosclerosis were divided into two groups: (1) those with a parent suffering from CHD (a myocardial infarction at <45 years of age) (n=46) and (2) Results and discussion In a previous study of a large family where serum lipoprotein (a) concentrations of three different generations were investigated, we showed that lipoprotein (a) increases with age. ' In another study we also found that newborn babies have very low lipoprotein (a) concentrations which slowly increase in the first weeks of life. In order to account for these fluctuations, lipoprotein (a) concentrations of the group with a parent with CHD and the control group were plotted against age (fig 1) . Significant differences between these two groups could be established above the age of 10 years only. Maximal differences were apparent at the age of 13 years.
On the basis of earlier findings of our group as well as of others, it seems well documented that lipoprotein (a) concentrations >300 mg/l are significantly correlated with premature atherosclerosis and myocardial infarction.3 From data in the present study it appears that this cut off concentration may be much lower in children below the age of about 10 years. We also conclude on the basis of the present study that lipoprotein (a) might be a significant discriminator for CHD only if measured in children of about 5 years or older.
We also measured the serum concentrations of glycosaminoglycan in the different groups and plotted them against age (fig 2) . In all age groups the concentrations were significantly higher in both groups of high risk children in comparison with control children. high risk children were not significantly different from each other, they were combined in fig 2 
